Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fenofibrate

A fibrate that lowers triglycerides and cholesterol by activating the PPAR-alpha receptor: a derivative of clofibrate, patented in 1969, it came into use in 1975, first in France. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?Its first name was procetofen: it was renamed fenofibrate to follow the WHO rules for naming medicines. In the body it is a prodrug that turns into fenofibric acid.

FenofibrateGo to the active ingredient →
FenofibrateActive ingredientFenofibrateCat. No. P-F023-001CAS 49562-28-9
Fenofibrate-d6Isotopically labelledFenofibrate-d6Cat. No. P-F023-010CAS 1092484-56-4

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.